Clinical Trial Update: An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children [Phase 3]

View source ↗

Summary

A Phase 3 effectiveness and safety trial comparing CONCERTA with immediate-release methylphenidate in children with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)
• Methylphenidate IR (Immediate-Release) (methylphenidate)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED